Nutrition

A talk about nutrition and my past. Fat Protein Cabs for more information you can read the amazing book good calories bad calories or the amazing schwarzbein principle.

Read this article:
Nutrition

Women in Science and Engineering (WISE)

Dear WISE Community Members,
Women in Science and Engineering (WISE) is currently recruiting community and professional mentors to participate in our college and pre-college mentoring programs. The mentoring program will allow students interested in your chosen fields to learn from you and share your excitement and passion for your area of study.
WISE has created a new format for our Mentoring Program this year: rather than having WISE staff create mentoring pairs, we will post mentors’ profiles online for high school students to browse and pick a college student and/or professional mentor to shadow for a day. WISE will not post mentors' contact information online; high school students interested in being matched with a mentor will contact WISE staff, who will assist with the match-up.
Remember that junior high and high school students will be reading your profile in addition to college age students, so try to keep it (somewhat) short and interesting! We recommend including a photo of yourself, as that helps personalize the profile (but it is not required). Please send your profile information and photo to sbs-wisemup@email.arizona.edu.
For further assistance on what to write for your personal profile please go to: http://wise.web.arizona.edu/content/mentor_information
If you were a WISE Mentor 2010-2011, and would like to use your profile from last year; please email us at: sbs-wisemup@email.arizona.edu and we will post your profile from last year on our webpage!
The deadline to become a mentor ends September 16, 2011 at 12:00 AM. We look forward to hearing from you and are so excited for another great year of mentoring!

Thank you,

Michelle Mendoza
WISE Mentoring Intern
Women in Science and Engineering (WISE)
maganame@email.arizona.edu
http://wise.web.arizona.edu

Alyssa Salanga
WISE Mentoring Intern
Women in Science and Engineering (WISE)
amsal247@email.arizona.edu

November R. Papaleo
Director, WISE
Women in Science and Engineering
University of Arizona
SIROW/GWS
520-626-9152
sbs-wisemup@email.arizona.edu

Source:
http://physiologynews.blogspot.com/feeds/posts/default?alt=rss

VivePeru’s Winter 2011 Internships

Interested in volunteering abroad this winter?

Apply to be a part of VivePeru’s Winter 2011 Internships!

Internships available for Peru Winter 2011:
Clinical Medicine
Engineering
Social Work

Informational meetings:
Wednesday, September 14 @ 3pm in Sabino Room (SUMC)
Thursday, September 22 @ 3:30pm in Presidio Room (SUMC)
Monday, September 26 @ 5pm in Agave Room (SUMC)

Applications are DUE October 1st at 12 noon PST.

Vive Peru is a nonprofit organization pending 501(c)(3) status. We are dedicated to fostering an understanding of Latin American and Peruvian culture and providing much-needed aid to Peruvian communities. We work to promote cultural understanding and implement innovative and self-sustainable programs in the areas of health, education, social work and engineering.
Visit us on Facebook to get an idea of what you will experience while in Peru! See pictures, learn more about our volunteer programs, and find information about costs and applications at http://www.facebook.com/viveperu.

Applications are available here: http://www.viveperu.org/apply

Please feel free to email us with any questions at info@viveperu.org!

--
Laura Moedano
University of Arizona
760-791-8990 | lmoedano@email.arizona.edu

Source:
http://physiologynews.blogspot.com/feeds/posts/default?alt=rss

Benefits of Electronic Medical Records (EMR) Software | 2011 Physician Survey

Courtesy of Software Advice.  Encourage to take the survey and share in the results.

According to an August 3 report from Robert Tagalicod, the new director of CMS Office of e-Health Standards and Services, 2,383 eligible providers have successfully attested for the Medicare Electronic Health Record (EHR) – or electronic medical record (EMR) – Incentive Program. One hundred hospitals have also attested.

This is great news. But what impact is technology having on the quality of care? Are physicians benefiting from all the improvements that EMR software promises to deliver?

We want to hear from you. We’re hosting a quick, 20-question survey about the advantages of electronic medical records. What kind of impact is EMR technology having on your practice? Are you realizing productivity and financial benefits? Quality of care improvements?

Let us know. We’ll publish the results back here in two weeks.

Read more: http://www.softwareadvice.com/articles/medical/benefits-of-emr-software-survey-1081611/#ixzz1WlNFcAVc

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Aperio Successfully Defends U.S. and International Patents Covering Line-Scanning Technology in Digital Pathology Systems

USPTO and European Patent Office uphold validity of Aperio patents

VISTA, Calif.--(BUSINESS WIRE)-- Aperio, the global leader in digital pathology solutions that improve patient care, today announced that the company has successfully defended key US and European patents covering line-scanning technology in digital pathology systems. These decisions uphold Aperio’s patent rights as the innovator of industry-leading technology in digital pathology.

With inventions and intellectual property that have contributed to the creation and growth of the digital pathology market, Aperio is the clear leader in digital pathology systems. The company has the broadest patent portfolio in the field, with more than 100 issued and pending patents worldwide, including a license to the Olympus/Bacus patents.

Facts surrounding Aperio’s recent patent victories include:

  • In August, 2008 Aperio was granted European Patent Number 1317685 covering its digital slide scanner technology, which was challenged in May, 2009 by Hamamatsu Photonics KK. In June, 2011 the European Patent Office held a hearing and determined that Aperio’s patent claim to a digital slide scanner that uses a line scan camera with a focus map was valid.
  • In March, 2004 Aperio was granted United States Patent Number 6,711,283 covering its digital slide scanner technology, which was challenged in November, 2009 by Hamamatsu Photonics KK. In March, 2011 the United States Patent and Trademark Office (USPTO) made a final determination that Aperio’s claim to a digital slide scanner that uses a line scan camera with a focus map to capture, compress and align digital image strips into a contiguous digital slide was valid.

“All leading digital pathology systems on the market today utilize line-scanning technology,” said Aperio CEO Dirk G. Soenksen. “Aperio invented the use of line-scanning for creating whole-slide images and has a rich portfolio of patents covering this technological breakthrough. The affirmation by both the US and European patent offices regarding the validity of our patents during contested proceedings significantly strengthens our patents, and we are delighted with the outcome. Aperio has invested considerable resources to create the most technologically advanced digital pathology systems available today, and we remain committed to defending our intellectual property.”

With more system installations than all other digital pathology vendors combined, Aperio is the global leader in digital pathology solutions. The company has an installed base of more than 850 systems in over 30 countries, including more than 550 systems in hospitals and reference laboratories. The company’s customers also include the 13 largest pharmaceutical companies as well as numerous biotechnology and government organizations.

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Sept 11 — Remembering 10 years later

At around 8 PM, ten years ago tomorrow I was on one of the last LaGuardia - Reagan Delta shuttles to leave New York City. I was returning from a trip to the laboratory at the hospital located on the U.S. Military Academy base in West Point, NY.  We had completed a successful AABB blood bank inspection and was returning to home to Washington.  It was a trip I had done several times previously as the pathology consultant to Keller Army Community Hospital and would do several more times over the next four years on frequent site visits and to cover frozen sections as Keller did not have a full-time pathologist.  This experience was the nidus for telepathology in the Army.  I figured there had to be an easier way to cover remote frozens than to fly to New York City or drive for hours each way for 15 minutes of work.  

NikkormatFT2 IMGP1333 On this particular trip, leaving LaGuardia, I was able to capture a few images of lower Manhattan and New York harbor. At the time, I was still taking pictures with a film camera (and still do sometimes but it is getting harder to find quality film and processing facilities...).  After takeoff I pulled out my old but trusty Nikkormat FT2 camera, snapped on my equally old but reliable 200mm lens and was able to get off 3 shots. 

The lighting cooperated despite slow film and my telephoto lens.  I like the grainy nature, particularly for black and white photos.  I did not realize what I had on the roll until many months later and saw what are likely some of the last images of the World Trade Center, particularly from the air.  I could not find the original negatives but was able to scan some 4x6 prints I had made.  About 12 hours after I took this picture, the first plane hit the North tower of the World Trade Center. 

WTC1 WTC3

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

MikroScan at CAP ’11

MikroScan and its digital pathology partners welcome you at booth #323 at CAP’11 for a hands-on product demonstration of our latest MikroScan D2 whole slide imaging system and partner products,  Pixcelldata’s Collibio and Smart Imaging Technology’s SIMAGIS Live.

They will unveil the smallest, most versatile hybrid telepathology and digital pathology solution on the market, the Mikroscan D2 image acquisition system. The live demonstrations and presentations will cover three pillars of products rich feature set:  D2-New

1. A decision support tool for pathologist, to assess tissue specimens, frozen sections and FNA biopsies in real-time and its impacts on the pathology workflow.

2. Remote live mode: A collaborative feature for early and rapid peer reviews and consults for pathology samples, allowing pathologist to come to a diagnosis at a rapid speed.

3. A rapidly deployable instrument and cloud computing system with flexibility to use various slide viewers, work flow management and laboratory information systems environments.

 

 

For more information check out MikroScan news.


 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

PerkinElmer to Acquire Caliper Life Sciences for Approximately $600 Million

  • Transaction enhances global leadership position in molecular imaging and detection forHuman and Environmental Health
  • Creates opportunity to significantly expand global delivery of compelling customer solutions in a broad range of high-growth end markets
  • Combined R&D expertise and intellectual property to accelerate innovation

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. (NASDAQ: CALP), a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.

Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, "The acquisition of Caliper Life Sciences brings innovative molecular imaging and detection technologies to our portfolio, complementing our world-leading offerings in life science, diagnostics, environmental and food markets."

Friel added, "The R&D, application expertise, and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization."

The combined technology platforms will expand PerkinElmer's deep portfolio of solutions and services for global customers including:

  • Broader offerings for molecular, cellular, animal and tissue imaging to enable translational medicine research;
  • Addition of a world-leading microfluidics platform for genomics and proteomics applications, for improved detection and screening through low sample use and efficiency;
  • High-value sample preparation technologies for key scientific workflow areas such as Next Generation DNA Sequencing;
  • More comprehensive solutions and services for identification of therapeutic response, biotherapeutics development and biologics QA/QC;
  • Platform technology additions to drive expansion into attractive areas such as detection for environmental contaminants and food pathogens; and
  • Broadening services capabilities, leveraging multi-vendor asset management, custom research, and profiling for contaminants and adverse effects.

Kevin Hrusovsky, chief executive officer, Caliper Life Sciences, noted, "We are delighted to become part of PerkinElmer. For 10 years, Caliper has partnered with strategic customers to develop a compelling suite of discovery technologies for broad life science applications."

Hrusovsky added, "I am excited by both PerkinElmer's ability to leverage its global reach for the delivery of solutions and the opportunity to accelerate the development of important advances that make a difference in improving human and environmental health. I am confident this is the correct strategic direction at this time for Caliper customers, shareholders and employees, and we are looking forward to becoming part of one of the leading companies in our industry."

Hrusovsky is anticipated to join the PerkinElmer senior leadership team following the close of the transaction.

The total purchase price represents a premium of 42% for Caliper Life Sciencesshareholders, relative to the closing price of $7.39 on Wednesday, September 7, 2011, the last trading day prior to today's announcement. The acquisition has received the unanimous support of the Boards of Directors of both companies, and is expected to close in the fourth quarter of 2011. The transaction is expected to be dilutive to PerkinElmer's 2012 GAAP earnings per share by approximately $0.05 and accretive to PerkinElmer's 2012 First Call consensus adjusted earnings per share by approximately $0.08.

The transaction is subject to customary closing conditions, including approval ofCaliper Life Sciences stockholders, and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

In connection with the transaction, Bank of America Merrill Lynch and Rothschildacted as financial advisors to PerkinElmer. Perella Weinberg Partners acted as exclusive financial advisor to Caliper Life Sciences, Inc., and provided a fairness opinion to the Caliper Life Sciences Board of Directors.

Source: PerkinElmer 

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

CAP Foundation September Case of the Month Available

September 2011
September Case Photo
VIEW CASE WITH
• MAC/PC Users: WebViewer
• PC users: ImageScope
(First time use - * Download software)
 

Case of the Month is a resource for pathologists to assess theirdiagnostic skills using digital whole slide imaging. Posted cases are selected from the CAP archives of the Performance Improvement Program in Surgical Pathology (PIP).

 

CLINICAL SUMMARY

LEFT PELVIS

A 49-year-old woman, with a radiologically aggressive pelvic mass underwent a left hemipelvectomy. A 15.0 x 11.0 x 9.0 cm tan-yellow mass occupying the medullary cavity of the iliac bone and extending into the surrounding soft tissues was identified. The cut surface of the mass was variegated tan-brown and myxoid with large foci of necrosis intermixed with areas having a more blue-gray chondroid appearance.

The master list with the correct answer

  1. Chondroblastic osteosarcoma
  2. Chondrosarcoma
  3. Dedifferentiated chondrosarcoma
  4. Enchondroma
  5. Synovial chondromatosis

View the appropriate diagnosis, critique and references

PREVIOUS CASE: MEDIASTINUM, POSTERIOR
A 32-year-old man with no significant previous medical history presented with sweating, headaches, and palpitations. A CT scan revealed a mass in his posterior mediastinum. Grossly, the 125 g mass measured 7.9 x 6.5 x 5.3 cm and was partially encapsulated with a deep red to pink cut surface. Sectioning revealed a single 3.1 cm cyst filled with serosanguinous fluid surrounded by red-pink, soft parenchyma. 
view case.

Go to CASE ARCHIVES

 

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Check out Aperio this Month at CAP ’11 and NSH 2011

CAP_NSH Eblast 090811 2
Why do more pathologists choose Aperio? 

Join us at the following September conferences to discover why.

CAP '11 - The Pathologists' Meeting™
Aperio Booth #511 - Gaylord Resort, Grapevine, TX
September 11-12, 2011

NSH 2011 - National Society for Histotechnology
Aperio Booth #124 - Duke Energy Convention Center,
Cincinnati, OH
September 18-20, 2011

  • Preview Spectrum™ Healthcare - the workflow solution everyone is talking about
  • Learn how seamlessly Aperio integrates with your LIS provider
  • Experience the new ScanScope® AT - the highest throughput instrument on the market
  • Discuss your institution's specific needs with our Digital Pathology Consultants

Contact the Aperio Events Team at events@aperio.comfor more information or to schedule a demonstration. 

 

 

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog